Skip to content
★ Sign in to follow
MS

Märta Segerdahl Storck

Executive
Asarina Pharma AB
Total declarations
21
Company
1
▲ Purchases (17 ops.)
€70k
▼ Sales (3 ops.)
€44k

Latest filing published 03 Sept 2021 for Asarina Pharma AB, €1,143.

Filing timeline

BuySale
Märta Segerdahl Storck

Insider track record

Disclosed buys
17
Disclosed sells
3
Signal history

Closed purchases

Market purchases
17

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Märta Segerdahl Storck: trading record in brief

Märta Segerdahl Storck is a declared insider of Asarina Pharma AB, with filings sourced from Finansinspektionen. Over a trading history stretching from 18 September 2018 to 3 September 2021, the count stands at 21 filings.

In open-market terms, that means 17 purchases worth €70k on one side and 3 sales worth €44k on the other. Purchases outweigh sales by €26k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 share grant. In 2021 alone, the filings show no purchases and 2 sales.

The median purchase comes to €1,019. Of 17 purchases, 3 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The latest filing, published on 3 September 2021, reports an open-market sale of €1,143 in Asarina Pharma AB. The last purchase on record was published on 18 March 2020, which is 2,426 days ago. The median gap between trade and publication is zero days: most filings appear on the same day. Under the Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.

Companies and markets linked to Märta Segerdahl Storck

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations20 total
  • ▼
    Annan ledande befattningshavareExecutivesAsarina Pharma AB
    11,635 SEK2FI-SE
    4,250 shares@ SEK 2.73761.2% of flowAktieISIN SE0011641794FI:csv-f0af16297a475faa3225
  • ▼
    Annan ledande befattningshavareExecutivesAsarina Pharma AB
    51,553 SEK3FI-SE
    18,832 shares@ SEK 2.73755.2% of flowAktieISIN SE0011641794FI:csv-cd9db2560785a08851ba
  • ▲
    Chief Medical OfficerExecutivesAsarina Pharma AB
    408,654 SEK26FI-SE
    18,832 shares@ SEK 21.7029.3% of flowAktieISIN SE0011641794FI:csv-cc59bf7e49dec684f2ef
    Canonical exit: 16 Jun 2020 (T+90)
  • ▲
    Chief Medical OfficerExecutivesAsarina Pharma AB
    151,500 SEK31FI-SE
    5,000 shares@ SEK 30.3016.0% of flowAktieISIN SE0011641794FI:csv-d35daa521d7aac641055
    Canonical exit: 18 May 2020 (T+90)
  • ▲
    Chief Medical OfficerExecutivesAsarina Pharma AB
    11,400 SEK11FI-SE
    500 shares@ SEK 22.801.2% of flowAktieISIN SE0011641794FI:csv-81e00e3942f303c0ad22
    Canonical exit: 10 Feb 2020 (T+90)
  • ▲
    Chief Medical OfficerExecutivesAsarina Pharma AB
    23,000 SEK11FI-SE
    1,000 shares@ SEK 23.002.4% of flowAktieISIN SE0011641794FI:csv-d579607a5114119dbcf2
    Canonical exit: 9 Feb 2020 (T+90)
  • ▲
    Chief Medical OfficerExecutivesAsarina Pharma AB
    18,800 SEK11FI-SE
    800 shares@ SEK 23.501.9% of flowAktieISIN SE0011641794FI:csv-620a0b27b9a09e4ad7a2
    Canonical exit: 9 Feb 2020 (T+90)
  • ▲
    Chief Medical OfficerExecutivesAsarina Pharma AB
    11,400 SEK11FI-SE
    500 shares@ SEK 22.801.2% of flowAktieISIN SE0011641794FI:csv-6de16275b252b62f414d
    Canonical exit: 6 Feb 2020 (T+90)
  • ▲
    Chief Medical OfficerExecutivesAsarina Pharma AB
    10,900 SEK11FI-SE
    500 shares@ SEK 21.801.1% of flowAktieISIN SE0011641794FI:csv-ace0eb0d43ca231b9cb8
    Canonical exit: 4 Feb 2020 (T+90)
  • ▲
    Chief Medical OfficerExecutivesAsarina Pharma AB
    10,080 SEK11FI-SE
    450 shares@ SEK 22.401.0% of flowAktieISIN SE0011641794FI:csv-8d304a8c87be26769b2c
    Canonical exit: 2 Feb 2020 (T+90)
  • ▲
    Chief Medical OfficerExecutivesAsarina Pharma AB
    10,750 SEK11FI-SE
    500 shares@ SEK 21.501.1% of flowAktieISIN SE0011641794FI:csv-486f50818202c86791ed
    Canonical exit: 29 Jan 2020 (T+90)
  • ▲
    Chief Medical OfficerExecutivesAsarina Pharma AB
    7,500 SEK23FI-SE
    300 shares@ SEK 25.000.8% of flowAktieISIN SE0011641794FI:csv-975d8b4a377671cb5077
    Canonical exit: 31 Dec 2019 (T+90)
  • ▲
    Chief Medical OfficerExecutivesAsarina Pharma AB
    10,200 SEK11FI-SE
    400 shares@ SEK 25.501.1% of flowAktieISIN SE0011641794FI:csv-b41e8ee959d7cd1bbceb
    Canonical exit: 9 Dec 2019 (T+90)
  • ▲
    Chief Medical OfficerExecutivesAsarina Pharma AB
    26,444 SEK11FI-SE
    1,022 shares@ SEK 25.8752.7% of flowAktieISIN SE0011641794FI:csv-814bb56138ba59b1f203
    Canonical exit: 28 Nov 2019 (T+90)
  • ▲
    Chief Medical OfficerExecutivesAsarina Pharma AB
    6,786 SEK11FI-SE
    260 shares@ SEK 26.100.7% of flowAktieISIN SE0011641794FI:csv-2f2746e3c5aab7710033
    Canonical exit: 28 Nov 2019 (T+90)
  • ◆
    Chief Medical OfficerExecutivesAsarina Pharma AB
    210,000 SEK13FI-SE
    10,000 shares@ SEK 21.0022.4% of flowAktieISIN SE0011641794FI:csv-e8425b7c6bdf0fab62ec
  • ▲
    Chief Medical OfficerExecutivesAsarina Pharma AB
    21,450 SEK11FI-SE
    825 shares@ SEK 26.002.2% of flowAktieISIN SE0011641794FI:csv-ba3b7b8bba61d6923eb7
    Canonical exit: 5 Dec 2019 (T+90)
  • ▲
    Chief Medical OfficerExecutivesAsarina Pharma AB
    10,360 SEK11FI-SE
    400 shares@ SEK 25.901.1% of flowAktieISIN SE0011641794FI:csv-05a6cb72d6ae3d5e4b85
    Canonical exit: 4 Dec 2019 (T+90)
  • ▲
    Chief Medical OfficerExecutivesAsarina Pharma AB
    10,352 SEK11FI-SE
    400 shares@ SEK 25.881.1% of flowAktieISIN SE0011641794FI:csv-f1d1772136859b3fbda6
    Canonical exit: 2 Dec 2019 (T+90)
  • ▲
    Chief Medical OfficerExecutivesAsarina Pharma AB
    5,940 SEK11FI-SE
    225 shares@ SEK 26.400.6% of flowAktieISIN SE0011641794FI:csv-c8423b3416328b75cde3
    Canonical exit: 26 Nov 2019 (T+90)

20 of 20 declarations